0001209191-15-078220.txt : 20151103 0001209191-15-078220.hdr.sgml : 20151103 20151103212855 ACCESSION NUMBER: 0001209191-15-078220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151026 FILED AS OF DATE: 20151103 DATE AS OF CHANGE: 20151103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lo Steven CENTRAL INDEX KEY: 0001501959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 151195320 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-10-26 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001501959 Lo Steven C/O CORCEPT THERAPEUTICS 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 VP Commercial Operations Common stock 2015-11-02 4 S 0 12500 4.00 D 0 D Common stock 2015-10-26 4 M 0 12500 3.29 A 12500 D Stock option 3.29 2015-10-26 4 M 0 12500 3.29 A 2025-02-17 Common stock 12500 0 D Exercise and hold. Fully exerciseable. 31,499 shares were cancelled upon termination of employment. /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact 2015-11-03